The objective of this study is to demonstrate any inner ear injury caused by drilling in mastoid surgery with prestin, outer hair cell motor protein specific to the cochlea. The patients with chronic otitis media requiring mastoidectomy (n = 21) and myringoplasty (n = 21) were included. Serum prestin level obtained from blood samples was measured before surgery and on postoperative days 0, 3, and 7 using Human Prestin (SLC26A5) ELISA Kit. All patients underwent the Pure Tone Audiometry (PTA) test before surgery and on the postoperative 7th day. The drilling time was also recorded for all patients who underwent mastoidectomy. In both mastoidectomy and myringoplasty groups, the postoperative serum prestin levels increased on days 0 and 7 (pday-0 = 0.002, pday-7 = 0.001 and pday-0 = 0.005, pday-7 = 0.001, respectively). There was no significant difference in the serum prestin levels between the two groups, postoperatively. The PTA thresholds at day 7 did not change in either group. A significant decline at 2000 Hz of bone conduction hearing threshold in both groups and a decline at 4000 Hz in the myringoplasty group were found. There was no correlation between the drilling time and the increase of prestin levels in the postoperative day 0, 3, and 7. Our results showed that mastoid drilling is not related to a significant inner ear injury. Although the myringoplasty group was not exposed to drill trauma, there was a similar increase in serum prestin levels as the mastoidectomy group. Also, a significant decline at 2000 Hz of bone conduction hearing threshold in both groups and a decline at 4000 Hz in the myringoplasty group were found. These findings suggest that suction and ossicular manipulation trauma can lead to an increase in serum prestin levels and postoperative temporary or permanent SNHL at 2000 and 4000 Hz. Level-4.
Background/Objectives: Oxidative endothelial injury and vitamin D deficiency have independently been implicated in diabetic vascular complications, yet their distribution across the glycemic spectrum, from normoglycemia through prediabetes to established type 2 diabetes, has not been systematically characterised. This study aimed to evaluate serum soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) and 25-hydroxyvitamin D3 [25(OH)D3] levels across the glycemic spectrum and to examine their associations with microvascular complications and metabolic parameters in prediabetic individuals and patients with type 2 diabetes mellitus (T2DM). Methods: In this prospectively recruited cross-sectional study, 80 adults were enrolled: 26 healthy controls, 27 prediabetic individuals, and 27 T2DM patients. Serum sLOX-1 was quantified by enzyme-linked immunosorbent assay (ELISA) and 25(OH)D3 by liquid chromatography–tandem mass spectrometry (LC-MS/MS). Between-group comparisons were performed using the Kruskal–Wallis test with Dunn’s post hoc correction. Spearman’s rank correlation and binary logistic regression were applied to examine associations with metabolic and microvascular parameters. Results: Serum sLOX-1 was significantly elevated in both prediabetic (median 10.75 ng/mL; p = 0.0397) and T2DM (8.83 ng/mL; p = 0.0209) groups compared to controls (3.50 ng/mL) in unadjusted analyses. After adjustment for age and body mass index (BMI) by quantile regression, the elevation persisted in the prediabetic group (adjusted ratio of medians = 2.91, p = 0.040) but was substantially attenuated and no longer significant in the T2DM group (ratio = 1.81, p = 0.265). Serum 25(OH)D3 was significantly lower in the T2DM group than in prediabetic individuals (12.11 vs. 22.69 ng/mL; p = 0.0024) but did not decline progressively across the glycemic spectrum; vitamin D deficiency (<20 ng/mL) was present in 78% of T2DM patients. In binary logistic regression (five predictors, events per variable (EPV) = 5.4), 25(OH)D3 (odds ratio (OR) = 0.922, p = 0.020) and log-transformed urinary albumin-to-creatinine ratio (logUACR; OR = 4.014, p = 0.001) were independently associated with T2DM status after adjustment for age and waist circumference, while sLOX-1 was not significant (OR = 1.058, p = 0.136). In unadjusted analyses, sLOX-1 correlated positively with waist circumference and glycated hemoglobin (HbA1c); both associations were no longer statistically significant after age adjustment. Conclusions: These findings show that sLOX-1 is elevated at the prediabetic stage independently of age and BMI, whereas the elevation in established T2DM was not robust to covariate adjustment. Lower 25(OH)D3 concentrations were associated with T2DM status in logistic regression, but this association was not significant when the reference group was restricted to normoglycaemic controls, indicating that the finding reflects the contrast between T2DM and prediabetic groups rather than a generalised pattern across the glycaemic spectrum. The two biomarkers were not significantly correlated with one another. Given the cross-sectional design, low EPV, and exploratory nature of all analyses, prospective validation in larger age-matched cohorts is required.